Niacinamide is a vitamin supplement. Vitamin B3 exists in many forms and niacinamide is a form that does not produce flushing (feeling hot) when taken in large amounts. It has been used in arthritis, pellagra, and early-onset type I diabetes.
Other names for niacinamide include: 3-pyridinecarboxamide, Nicamid, Nicotinamide, Nicosedine, Nicotinic Acid Amide, Nicotylamidum, and Vitamin PP.
Ask your doctor, nurse, or pharmacist if you need more information about this medicine or if any information in this leaflet concerns you.
Tell your doctor if you
Talk with your caregiver about how much niacinamide you should take. The amount depends on the strength of the medicine and the reason you are taking niacinamide. If you are using this medicine without instructions from your caregiver, follow the directions on the medicine bottle. Do not take more medicine or take it more often than the directions tell you to.
Keep all medicine locked up and away from children. Store medicine away from heat and direct light. Do not store your medicine in the bathroom, near the kitchen sink, or in other damp places. Heat or moisture may cause the medicine to break down and not work the way it should work. Throw away medicine that is out of date or that you do not need. Never share your medicine with others.
Do not take niacinamide without talking to your doctor first if you are taking:
Call your doctor right away if you have any of these side effects:
You may have the following side effects, but this medicine may also cause other side effects. Tell your doctor if you have side effects that you think are caused by this medicine.
1. Anon: Recommended Dietary Allowances 10th ed. The National Academy of Sciences, National Academy Press, Washington, DC; 1989.
2. Vague PH, Vialettes, Lassmann-Vague et al: Nicotinamide may extend remission phase in insulin dependent diabetes (letter). Lancet 1987; I:619.
3. Pozzili P, Visalli N, Ghirlanda G et al: Nicotinamide increases c-peptide secretion in patients with recent onset type 1 diabetes. Diabetic Med 1989; 6:568.
4. Chase HP, Butler-Simon, Garg S et al: A trial of nicotinamide in newly diagnosed patients with type 1 (insulin dependent) diabetes mellitus. Diabetologia 1990; 33:444-446.
5. Lewis CM, Canafax DM, Sprafka M, et al: Double-blind randomized trial of nicotinamide on early onset diabetes. Diabetes Care 1992:15:121-123.
6. Hulshof JH & Vermeij P: The effect of nicotinamide on tinnitus: a double blind controlled study. Clin Otolaryngol 1987; 12:211-214.
7. Zackheim HS, Vasily DB: Westphal ML et al: Reactions to niacinamide (letter). J AM Acad Dermatol 1981; 4:736-737.
8. Hoffer A: Safety, side effects and relative lack of toxicity of nicotinic acid and nicotinamide. Schizophrenia 1969; 1:78-87.
9. Winter SL & Boyer Jl: Hepatic toxicity from large doses of vitamin B3 (nicotinamide). N Engl J Med 1973; 289: 1180-1182.
10. Zackheim HS: Topical 6-aminomicotinamide plus oral niacinamide therapy for psoriasis. Arch Dermatol 1978; 114:1632-1638.
11. Riley MR (ed): Drug Facts and Comparisons. Facts and Comparisons Inc, St. Louis, MO; 2000.
12. AMA Department of Drugs: AMA Drug Evaluations, 6th ed. American Medical Association, Chicago, IL; 1986.
13. Bourgeois BFD, Dodson WE & Ferrendelli JA: Interactions between primidone, carbamazepine, and nicotinamide. Neurology 1982; 32: 1122-1126.
12. Product Information: Niaspan, niacin, extended release tablet. KOS Pharmaceuticals, Miami, FL, USA, 1997.
13. Figge HL, Figge J, Souney PF et al: Nicotinic acid: a review of its clinical use in the treatment of lipid disorders. Pharmacotherapy 1988; 8(5):287-294.
14. Crouse JR III: New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug. Coron Artery Dis 1996; 7(4):321-326.
15. Product Information: Niacor(R), niacin (niacinamide). Upsher-Smith Laboratories, Minneapolis, MN, 2000.